Citric/citrate buffer: an effective antiglycolytic agent
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background:In order to minimize the influence of glycolysis on diabetes mellitus (DM) diagnostic tests, we have compared the behavior of citric/citrate, fluoride additives and gel-serum with plasma-heparin under careful preanalytical conditions. Subsequently, we compared the effectiveness of both fluoride and citric additives at different pre-centrifugation times. Finally, the influence of citric/citrate collection tube on diagnostic tests results was evaluated. Methods:The first study of 80 voluntary patients assessed the glucose bias of citric/citrate, fluoride additive tubes and gel-serum tubes versus plasma-heparin tubes at several medical decision cut-offs (MDC). The second study performed with 72 volunteers evaluated additives, simulating transport times to the laboratory and centrifugation delay periods. Final evaluation compares the proportion of positive tests in total tests carried out in two different periods. Results:When citric/citrate (n=79) and fluoride tubes (n=60) were compared with plasma-heparin under controlled preanalytical conditions, both met the bias specification for plasma glucose (±1.8%) at seven MDC. On the contrary, serum samples (n=15) did not meet it at five MDC. In the second study, differences in glucose values at distinct pre-centrifugation times were not statistically significant for citric/citrate tubes, but significant for fluoride tubes and also for comparison of fluoride and citric/citrate tubes. Hemolysis in fluoride tubes was higher. Citric/citrate tube implementation in our laboratory caused an increase in positive diagnostic tests that were only statistically significant for gestational diabetes mellitus (GDM) screening. Conclusions:Citric/citrate additive tube is equivalent to plasma-heparin avoiding glycolysis completely and immediately under careful preanalytical conditions even with a 3-h delay in plasma separation. According to used MDC we have not statistically significantly increased the diagnoses of DM cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924 · cited 1×
“These criteria for the GDM [14] are those proposed by National Diabetes Data Group (NDDG) in 1979 [19] with cut-offs higher than those proposed by Carpenter and Coustan in 1982 [20].”
MethodSacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Diabetes Care · doi:10.2337/dc11-9998 · Cited by 718
Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis
Gambino, R., Piscitelli, J., Ackattupathil, T. A., Theriault, J. L., Andrin, R. D., Sanfilippo, M. L., & Etienne, M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.121707 · Cited by 160 · cited 5×
“Gambino [11], for instance, obtained 0.”
BackgroundResultInfluentialStabilization of glucose in blood samples: why it matters
Bruns, D. E., & Knowler, W. C. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.126037 · Cited by 125 · cited 1×
“Glycolysis ex-vivo [1] is the main interference factor in glycemia determination when analysis is delayed, the specimen is not kept cold enough [2] and centrifugation cannot be carried out in a short period of time after venipuncture, especially in presence of leukocytosis, thrombocytosis or elevated hematocrit.”
BackgroundM. Stahl, L. G. M. J. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655101300133612 · Cited by 79 · cited 1×
“Glycolysis ex-vivo [1] is the main interference factor in glycemia determination when analysis is delayed, the specimen is not kept cold enough [2] and centrifugation cannot be carried out in a short period of time after venipuncture, especially in presence of leukocytosis, thrombocytosis or elevated hematocrit.”
BackgroundA new method of inhibiting glycolysis in blood samples
Uchida, K., Matuse, R., Toyoda, E., Okuda, S., & Tomita, S. (1988) · Clinica Chimica Acta · doi:10.1016/0009-8981(88)90125-8 · Cited by 53
Cited by
Daly, N., Flynn, I., Carroll, C., Farren, M., McKeating, A., & Turner, M. J. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.247478 · Cited by 50
Pre-analytical and analytical aspects affecting clinical reliability of plasma glucose results
Pasqualetti, S., Braga, F., & Panteghini, M. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.03.009 · Cited by 41
“in PG results derived from the shift from fluoride (the additive currently in use in the majority of the healthcare facilities) to citrate tubes (Table 1) [20-28].”
BackgroundBlood Glucose Determination: Effect of Tube Additives
(2018) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2017.12.003 · Cited by 28
Carey, R., Lunt, H., Heenan, H. F., Frampton, C. M. A., & Florkowski, C. M. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.05.017 · Cited by 26
Ridefelt, P., Åkerfeldt, T., & Helmersson-Karlqvist, J. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.02.022 · Cited by 21
Metadata
- Authors
- del Pino, I. G., Constanso, I., Mourín, L. V., Safont, C. B., & Vázquez, P. R.
- Venue
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Publisher
- Walter de Gruyter GmbH
- Published
- 2013-04-02
- Volume
- 51
- Issue
- 10
- Pages
- 1943-1949
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W1995611671
- Cited by
- 33
- References
- 8
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.